• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of highest risk product domestic inspections in the month resulting in a category of classifications called OTHER

Dictionary: The number of highest-risk product inspections where one of the following four outcomes occurred. 1. Referred to State for Follow-Up: the findings of the inspection were such that there is no federal jurisdiction over the apparent violation in question or it is determined that State action is the most efficient method of obtaining the establishment’s compliance with Federal laws, regulations or administrative requirements. 2. Referred to Center: the Establishment Inspection Report has been referred to the appropriate Center for a final inspection district decision. 3. Not Yet Completed by Investigator: the inspection has been completed but the investigator has not yet reported [into the database] what district decision will be recommended. 4. Not Yet Endorsed by Investigations: the investigator’s recommendation is that the district decision should be OAI but this recommendation has not yet been endorsed (reviewed and approved) by the investigator’s supervisor

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetNumber Classified as Other
Oct 2010N/A7
Nov 2010N/A10
Dec 2010N/A11
Jan 2011N/A6
Feb 2011N/A7
Mar 2011N/A14
Apr 2011N/A16
May 2011N/A16
Jun 2011N/A34
Jul 2011N/A24
Aug 2011N/A52
Sep 2011N/A81

FY 2011 Overall: 278

Percent of highest risk domestic inspections in the month resulting in a classification of Other

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetPercent Classified as Other
Oct 2010N/A1
Nov 2010N/A1
Dec 2010N/A1
Jan 2011N/A1
Feb 2011N/A1
Mar 2011N/A1
Apr 2011N/A2
May 2011N/A1
Jun 2011N/A3
Jul 2011N/A3
Aug 2011N/A5
Sep 2011N/A10

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.